background: The involvement of biogenic monoamines in early ('preneural') embryogenesis has been well documented in lower vertebrates, but much less information is available about the role of these molecules in the earliest stages of development in mammals, including humans.
Introduction
The development of the preimplantation embryo is regulated by its genetic program as well as by factors of the surrounding environment. The developing embryo is surrounded by oviductal fluid, which is composed of selected serum components and secretory products of reproductive tract cells (Leese, 1988; Buhi et al., 2000) . It has been well documented that growth factors and cytokines can regulate fundamental cellular processes, such as proliferation, differentiation and cell death in preimplanation embryos (Díaz-Cueto and Gerton, 2001; Hardy and Spanos, 2002; Richter, 2008) . Less attention has been paid to other molecules, such as biogenic monoamines, present in the mammalian reproductive tract. Biogenic monoamines have been identified in the follicular and oviductal fluids of several mammalian species, including humans (Fernandez-Pardal et al., 1986; Khatchadourian et al., 1987; Murdoch, 1990; Bodis et al., 1993; Way et al., 2001) . Accumulating evidence indicates that these compounds can (besides their well-known neurotransmitter function) play an important role in basic developmental processes such as embryogenesis and morphogenesis, controlling cell proliferation, differentiation and migration (Pendleton et al., 1998; Weiss et al., 1998; Herlenius and Lagercrantz, 2001; Anitole-Misleh and Brown, 2004) .
The involvement of biogenic monoamines in early ('pre-neural') embryogenesis has been well documented in lower vertebrates (Lauder, 1993; Buznikov et al., 1996; Buznikov et al., 2001 ), but much less information is available about the role of these molecules in the earliest stages of development in mammals, including humans. Histamine, serotonin and catecholamines have been the most intensively studied biogenic monoamines in relation to mammalian embryogenesis. However, the majority of published data relate to later stages of embryonal development or to the entire prenatal period, demonstrating important roles of histamine (Brew and Sullivan, 2006; Maintz et al., 2008) , serotonin (Cô té et al., 2007; Salas et al., 2007) and catecholamines (Miller and Chernoff, 1995; Mulder et al., 2002) . This minireview summarizes available data on the expression of histamine, serotonin and adrenergic receptors during mammalian preimplantation development, and discusses the potential roles of biogenic monoamines in very early pregnancy.
Expression of receptors for biogenic monoamines in preimplantation embryos and ovulated oocytes
Biogenic monoamines exert their effects in the cell through binding to membrane receptors. These receptors are either ion channels or G protein-coupled receptor proteins. Receptor channels (ligand-gated ion channels) are composed of five transmembrane subunits. Binding the ligand induces opening of the channel, which enables the passage of appropriate ions. G protein-coupled receptors are characterized by seven transmembrane domains connected by three cytoplasmic and three extracellular loops. Binding the ligand induces coupling of the receptor to heterotrimeric GTP-binding proteins (G proteins), which then activate various effectors, such as adenylyl cyclase (AC) (Gs proteins stimulate and Gi proteins inhibit the enzyme, leading to increased or decreased cAMP levels, respectively), phospholipase C (Gq proteins stimulate the enzyme, resulting in formation of diacylglycerol, inositol 1,4,5-triphosphate and increase of Ca 2+ levels), and other proteins involved in signal transduction (Krauss, 2001; Hur and Kim, 2002) . Histamine binds to 4 histamine receptor subtypes, and serotonin (5-hydroxytryptamine, 5-HT) binds to 14 serotonin receptor subtypes which can be classified into 7 classes (Table I) . Catecholamines (adrenalin, noradrenalin, dopamine) bind to nine subtypes of adrenergic receptors (classified into three types: a1, a2, b), and to five subtypes of dopamine receptors (classified into two types: D1-like and D2-like, Table I ).
Expression of histamine receptors was examined in mouse preimplantation embryos at all developmental stages, and H2R mRNA was detected in blastocysts but not at earlier stages. Ligand-binding assays confirmed that the mRNA is translated, and that the receptor is capable of binding specific ligands. The binding sites were localized predominantly in the trophoectoderm cells of blastocysts suggesting the role of the H2 receptor in implantation (Zhao et al., 2000) .
Expression of several serotonin receptors has been demonstrated in mouse preimplantation embryos and oocytes. Veselá et al. (2003) analyzed expression of three types of serotonin receptors (5-HT 1B , 5-HT 2C and 5-HT 1D ), and found 5-HT 1D receptor mRNA in ovulated oocytes, and preimplantation embryos. Examining other members of the serotonin receptors family, Amireault and Dubé (2005a) detected 5-HT 7 mRNA in mouse oocytes and early preimplantation embryos (5-HT 7 , 5-HT 2A and 5-HT 2B mRNAs were also detected in ovarian cumulus cells), whereas 5-HT 2C , 5-HT 4 and 5-HT 6 receptors were not detected either in oocytes or in cumulus cells. The expression of 5-HT 7 receptor was also confirmed at the protein level. Comparison of 5-HT 2 and 5-HT 7 mRNAs expression in mouse and hamster metaphase II oocytes suggests species-specific differences in the distribution of serotonin receptors in mammalian oocytes and early embryos (Amireault and Dubé, 2005a) . Detection of a 5-HT 2A -specific expressed sequence tag (EST) in human oocytes suggests that this receptor type is probably expressed in humans (Neilson et al., 2000) .
Expression of all members of the adrenergic receptor family has been studied in mice. Transcripts for b2-and b3-adrenergic receptors were detected in mouse ovulated oocytes and preimplantation embryos. The expression of b2-adrenoceptor was also confirmed at the protein level, which supports the opinion that functional signaling from the beta-adrenergic receptor can exist in cells of preimplantation embryos (Č ikoš et al., 2005) . Among alpha-adrenergic receptors, only a2C-adrenoceptor was found in mouse ovulated oocytes and preimplantation embryos. The results indicated that transcription of a2C-adrenoceptor gene in the oocyte is followed by elimination of this maternal transcript (after oocyte fertilization), and the resumption of a2C-adrenoceptor gene transcription occurs around the 8 -16-cell stage (Č ikoš et al., 2007) . These results indicate that two types of adrenergic receptors, which couple primarily to G proteins with opposite actions on AC activity, are expressed in mouse ovulated oocytes and preimplantation embryos. Receptors for biogenic monoamines whose expression has been documented in mammalian preimplantation embryos and oocytes are shown in Table II . Additional receptors can be found in microarray and EST experiments, but the data remains to be verified.
Although the presence of biogenic monoamine receptors in cells of preimplantation embryos could be a product of stochastic expression (Chelly et al., 1989; Halley et al., 2008) , several results indicate that expression of these genes can be regulated. Many neuronal genes, including receptors for biogenic monoamines, are expressed in embryonic stem (ES) cells which are derived from preimplantation embryos and retain the developmental potency of embryonal founder cells (Ivanova et al., 2002; Ramalho-Santos et al., 2002) . The dual functionality of the REST (RE1 silencing transcription factor, a key regulator of many neuronal genes) in ES and in terminally differentiated non-neuronal cells has been proposed to explain the basal level of neuronal gene expression in ES (Ballas et al., 2005 Adrenalin/ noradrenalin a1A-AR, a1B-AR, a1D-AR Gq a2A-AR, a2B-AR, a2C-AR Gi b1-AR, b2-AR, b3-AR Gs Dopamine DR1, DR5 Gs DR2, DR3, DR4 Gi Some receptors exhibit multiple potential couplings to different G proteins, depending on cell types and context (Watson and Arkinstall, 1994; Hill et al., 1997; Hoyer et al., 2002) . REST-binding motifs have been identified in several genes encoding receptors for biogenic monoamines (Sun et al., 2005; Otto et al., 2007) . In addition to REST, other factors participate in regulation of neuronal genes (Kim et al., 2006; Wen et al., 2009) , and some of them can also be required for maintaining pluripotency (Ying et al., 2003; Johnson et al., 2008; Singh et al., 2008) . The basal level of neuronal gene expression not only helps to maintain the genes in a state that is permissive for subsequent induced levels of expression (Ballas et al., 2005) , but can also provide functional proteins, as demonstrated for dopamine and adrenergic receptors in mouse ES Kim et al., 2008) . These results are consistent with a default model for neural development (Tropepe et al., 2001; Vallier et al., 2004; Smukler et al., 2006) , suggesting that pluripotent early embryonal cells (such as cells of preimplantation embryos or ES cells) do not require numerous signals to become neural cells, because they already express some genes encoding neuronal traits. In any case (regulated or stochastic expression), receptors for biogenic monoamines expressed in cells of preimplantation embryos have been shown to be functional (at least in the rodent model, see below), which means that they can induce a cell response after their occupation with ligands.
Sources of biogenic monoamines in the female reproductive tract
Biogenic monoamines found in fluids and tissues of the female reproductive tract can originate from the maternal circulation or innervation of reproductive organs, or they can be produced by parenchymal or stromal cells of the reproductive tract. The production of these molecules by the oocyte or preimplantation embryo itself is a further possibility. Identification of cells expressing enzymes which synthesize biogenic monoamines can reveal local sources of these molecules in the reproductive tract. Expression of histamine-synthesizing enzyme, histidine decarboxylase (HDC), has been demonstrated in mouse uterine epithelial cells, but not in preimplantation embryos. Maximal uterine expression of HDC was found on the day of implantation, which supports the importance of histamine for the implantation process (Paria et al., 1998; Zhao et al., 2000) . In humans, uterine mast cells are thought to be the main source of histamine (Liu et al., 2004a,b) . Moreover, the human preimplanation embryo has been shown to be capable of producing the embryonic histamine-releasing factor, which can induce the release of histamine from uterine mast cells (Cocchiara et al., 1988 (Cocchiara et al., , 1992 (Cocchiara et al., , 1996 .
Mast cells and nerve fibers were supposed to be main local sources of serotonin in rat female reproductive tract (Juorio et al., 1989; Amenta et al., 1992) . Serotonin was also detected in mouse and hamster oocytes, and in mouse cumulus cells and preimplantation embryos from the zygote to blastocyst stage (Ilˇková et al., 2004; Amireault and Dubé, 2005b; Basu et al., 2008) . To test the possibility of local serotonin production, expression of tryptophan hydroxylase (TPH, the rate-limiting enzyme for serotonin production) was examined in mouse cumulus cells, oocytes and preimplantation embryos. Walther and Bader (1999) detected TPH protein in zygotes, but not in unfertilized oocytes. However, the antibody used in this study did not distinguish between the two TPH isoforms-TPH1 and TPH2. TPH1 mRNA and protein was shown in mouse cumulus cells, but not in oocytes and preimplantation embryos from the zygote to blastocyst stage (Amireault and Dubé, 2005b) . The discrepancies between these reports can be explained by the different expression profile of the two TPH isoforms. Basu et al. (2008) demonstrated that TPH2 transcript is expressed in mouse oocytes and 2-cell embryos, whereas TPH1 transcript was not detected at any preimplanation stage. Taken together, the results indicate that ovarian cumulus cells and early cleavage embryos can be a physiological local source of serotonin (expressing TPH1 and TPH2 isoform, respectively), and suggest the possibility of autocrine/paracrine regulation by serotonin at this stage of development. On the other hand, expression of serotonin-specific transporter SLC6A4 in mouse oocytes and preimplantation embryos (from zygote to blastocyst stage) indicates that serotonin detected in these cells can be a result of serotonin transfer from the environment. The uptake of exogenously added serotonin demonstrated in oocytes, 4-cell stage embryos and blastocysts cultivated in vitro, supports this opinion. Thus, it seems that serotonin in oocytes and early embryos can arise from a combination of endogenous production and uptake from the surrounding milieu (Amireault and Dubé, 2005b; Basu et al., 2008) .
Catecholamines and their synthesizing enzymes have been demonstrated in tissues of the female reproductive tract in several mammalian species. Noradrenalin as well as tyrosine hydroxylase (TH) dopamine b-hydroxylase (DBH) activity has been detected in different parts of rabbit oviduct (Belmar et al., 1983; Bernet et al., 1987) . Dopamine, noradrenalin and adrenalin were also shown in human and cow oviductal tissue (Helm et al., 1982; Kotwica et al., 2003) . Intraovarian neurons were identified as a site of TH and DBH gene expression in the primate ovary. Moreover, DBH, which catalyzes the conversion of dopamine to noradrenalin, was detected in oocytes; expression of a dopamine transporter in primate oocytes enabled the uptake of exogenous dopamine and its conversion to noradrenalin (Mayerhofer et al., 1998) .
The role of biogenic monoamines in preimplantation development
Histamine Administration of histamine receptor H2 agonist to mouse blastocysts incubated in vitro stimulated cAMP accumulation and blastocyst hatching, which suggests that H2 receptor is biologically functional in these cells. The treatment of mouse blastocysts with H2R antagonist resulted in implantation failure after transfer of blastocysts to pseudopregnant recipients, and large number of the transferred blastocysts were zona-encased 1 day after the transfer (Zhao et al., 2000) . These results indicate that interactions between maternal histamine, produced mainly by uterine epithelial cells (Paria et al., 1998) and the blastocysts H2 receptor (activating AC) play an important role in mouse blastocyst implantation. In humans, histamine is produced probably mainly by uterine mast cells, and two histamine receptors (H1R, H2R) were detected in a cell line derived from first-trimester cytotrophoblasts; H1 receptor signaling (involving phospholipase C and inositol 1,4,5-triphosphate pathway) was demonstrated to mediate the stimulatory effect of histamine on the throphoblast invasion (Liu et al., 2004a,b) . These results suggest possible speciesspecific or stage-specific differences in histamine signaling during mammalian early embryo development. Normal viability and fertility of HDC-or H2R-deficient mice suggest that histamine is not absolutely necessary for embryo implantation, and some compensatory mechanisms replacing histamine signaling can probably be utilized in animals receiving high doses of H2R blockers or lacking HDC and H2R (Kobayashi et al., 2000; Ohtsu et al., 2001; Agrawal and Jose, 2009) . Blastocyst hatching and implantation are complex processes encompassing molecular pathways which involve the action of a range of biomolecules, such as hormones, growth factors, cytokines, proteases, lipid mediators, adhesion molecules and transcription factors (Dey et al., 2004; Armant, 2005; Seshagiri et al., 2009; Yoshinaga, 2010) . The importance of prostaglandins in blastocyst hatching and implantation has been well documented (Huang et al., 2004; Wang and Dey; Kennedy et al., 2007) , and data obtained in several cell types indicate that the expression of enzymes synthesizing these lipid mediators can be influenced by histamine (Dux et al., 1982; Cianchi et al., 2005; Tan et al., 2007) . The combined involvement of histamine and prostaglandins in the implantation process has been demonstrated in mice, rabbits and rats (Saksena et al., 1976; Hoos and Hoffman, 1983; Agrawal and Jose, 2009 ). Histamine has also been shown to stimulate av-b3 integrin expression in human trophoblast cells (Szewczyk et al., 2005 (Szewczyk et al., , 2006 , which suggests that adhesion molecules could be further cellular targets of histamine receptor signaling in the implanting embryo.
Several signaling pathways leading from histamine receptors have been described in various cell types. Activated H2R couples preferentially to Gs proteins which stimulate AC, resulting in increased cAMP level and PKA (cAMP dependent protein kinase) activation. In addition to AC, Gs proteins can activate other effector enzymes-signaling pathways (Hill et al., 1997; Hur and Kim, 2002) . The only information on histamine signaling in cells of preimplantation embryos is presented in the biochemical cascade 'H2R-AC-cAMP' described in mouse blastocysts (Zhao et al., 2000) . Since cAMP effects in the cell are mediated mainly through PKA, phosphorylation of as yet unidentified target molecules by PKA can be expected in mouse blastocyst cells after H2R activation. Participation of cAMP and PKA in the stimulation of expression of Cox-2 (the inducible, rate-limiting enzyme in prostaglandin biosynthesis) has been demonstrated in a variety of cell types (Kang et al., 2007; Klein et al., 2007) . Increased expression of several integrin subunits mediated by cAMP/PKA, and the involvement of Gs-coupled prostaglandin receptors in this process has been demonstrated in mouse mastocytoma cells (Hatae et al., 2003; Okada et al., 2011) . In addition, another type of Gs-coupled receptor has been shown to stimulate the integrin-mediated cell adhesion in human ovarian carcinoma cells, and cAMP induces this effect through a PKA-independent mechanism (Rangarajan et al., 2003) . Besides the signal transduction via cAMP, H2R activation can also trigger phospholipid signaling pathways leading to the increase of intracellular Ca 2+ levels in some cell types (Del Valle and Gantz, 1997; Wang et al., 1998; Kwan et al., 2009 ), but H2R receptor probably does not induce these pathways in blastocysts (Liu et al., 2004a,b) . Although several aspects of histamine action in preimplantation embryos remain to be elucidated, the expression and biological functionality of histamine receptors in blastocysts suggest that the treatment of mothers with histamine receptor ligands could have an impact on early embryo development. H2 receptor antagonists are widely used for the treatment of peptic ulcer diseases and gastroesophageal reflux diseases (which are common disorders also in pregnancy), and the above-mentioned data suggest that these drugs could be potentially hazardous if taken around the time of embryo implantation. The influence of H2R blockers taken by women during pregnancy has been analyzed in several studies, and the majority of data indicate no significant increase in the incidence of major malformations or other pregnancy complications (Magee et al., 1996; Garbis et al., 2005; Matok et al., 2010) . However, the effect of drugs (received by mothers) on the human peri-implantation embryo is difficult to analyze, so that no definite conclusions can be made with respect to this embryonal period. Experiments performed in animal models call for caution. The impaired embryo implantation after administration of HDC inhibitors or H2R antagonist (famotidine, ranitidine-frequently used as anti-ulcer agents) has been demonstrated in rabbits, mice and rats (Dey, 1981; Zhao et al., 2000; Agrawal and Jose, 2009 ).
Serotonin
The serotonin receptor is biologically functional in the mouse preimplantation embryo, as indicated by inhibition of embryo development after administration of specific ligands in vitro. Embryo exposure to serotonin or the specific 5-HT 1D receptor agonist sumatriptan, significantly reduced the cell number, and increased the incidence of dead cells (Veselá et al., 2003; Ilˇková et al., 2004) . On the other hand, the impaired development of preimplantation embryos (reduced cell proliferation, abnormalities in blastocyst formation) was also found after decreasing maternal serotonin levels by administration of an inhibitor of TPH (the rate-limiting enzyme of serotonin synthesis) to pregnant mice (Khozhai et al., 1995) . These results indicate that the effect of serotonin on preimplantation embryo development can depend on the context of the surrounding milieu, which is more complex in vivo than in vitro. Moreover, differences in expression of Gi-and Gs-coupled serotonin receptors during the preimplantation period (Table II) suggest that serotonin could activate different signaling pathways at different developmental stages. Since the embryos in the experiment by Ilˇková et al. (2004) were exposed to serotonin from the 4-cell to blastocyst stage, and sumatriptan used in the experiment by Veselá et al. (2003) is a 5-HT1 D/B receptor-specific agonist, the inhibitory effect of serotonin/sumatriptan found in these in vitro experiments was mediated presumably by 5-HT 1D receptor. A combination of two effects probably participated in the inhibitory influence of a decreased level of endogenous serotonin found in the in vivo experiment by Khozhai et al. (1995) : the reduction in both 5-HT 1D (Gi-coupled) and 5-HT 7 (Gs-coupled) receptor activity up to the 4-cell stage, and the reduction in 5-HT 1D activity at higher developmental stages (when 5-HT 7 receptor is no more expressed). In addition, interactions with other receptor signaling (triggered by other ligands present in the oviduct) must be taken into account under in vivo conditions. Serotonin receptors couple to Gs, Gi or Gq proteins. Some serotonin receptor subtypes can couple to more than one G protein, and are able to activate different signaling pathways depending on the cellular environment (Raymond et al., 2001; Hoyer et al., 2002) . Signaling pathways activated by serotonin receptors have not yet been described in preimplantation embryos. Limited data about serotonin signal transduction are available in oocytes and surrounding cumulus cells. Serotonin has been shown to increase cAMP and intracellular Ca 2+ levels in mouse ovary cumulus cells. The usage of selective agonists indicated that the cAMP increase was mediated mainly by the 5-HT 7 receptor, and the Ca 2+ increase was probably linked to the 5-HT 2B receptor; cross-talk between the two pathways was observed (Amireault and Dubé, 2005a) . In contrast, no effect of serotonin on cAMP and Ca 2+ was found in metaphase II oocytes, suggesting that other signaling pathways may be involved, or that serotonin receptors are not functional at this stage of oocyte development. Another explanation is offered in an analysis of the expression profile of serotonin receptors (Table II) . 5-HT 1D and 5-HT 7 receptors (both detected in mouse metaphase II oocytes) couple preferentially to Gi and Gs proteins, respectively, and activation of both these receptors by serotonin can result in unchanged cAMP level. AC is functional in metaphase II oocytes, because forskolin (a well-known AC stimulator) can induce a robust cAMP increase in these cells (Amireault and Dubé, 2005a) . Moreover, there are data indicating possible involvement of serotonin receptors in regulation of cAMP level at earlier stages of oocyte development (Mehlmann, 2005; Sheng et al., 2005) . Results obtained in preimplantation embryos indicate that serotonin can influence proliferation of early embryonic cells, which suggest the involvement of mitogen-activated protein kinases (MAPKs) in the signal transduction.
5-HT 1 and 5-HT 7 receptors have been shown to stimulate or inhibit proliferation by influencing the activity of MAPKs in various cell types using several signaling pathways (Liu et al., 2004a,b; Leó n-Ponte et al., 2007; Pai et al., 2009; Frampton et al., 2010) . Because of the possibility of external serotonin uptake by oocytes and preimplantation embryos (Amireault and Dubé, 2005b; Basu et al., 2008) , receptor-independent signaling processes such as serotonylation (Walther et al., 2003; Paulmann et al., 2009 ) must be taken into account as well. Basu et al. (2008) demonstrated co-localization of serotonin with mitochondria in cells of mouse preimplantation embryos and the ability of serotonin to modulate mitochondrial potential in these cells. The deleterious influence of aberrant mitochondrial potential or mitochondrial injury on early embryo development has been demonstrated in several studies (Wilding et al., 2001; Van Blerkom et al., 2002; Acton et al., 2004; Thouas et al., 2004) . Moreover, serotonin and other biogenic monoamines are degraded by mitochondrial bound enzymes-monoamine oxidases (MAO), and it has been suggested that excessive activity of these enzymes may lead to mitochondrial damages in neural cells as well as in other cell types (Nocito et al., 2007; Bortolato et al., 2008) . Furthermore, hydrogen peroxide produced by oxidation of monoamine substrates can induce oxidative stress resulting in neuronal death (Naoi et al., 2006) . Besides intracellular actions, serotonin can influence mitochondrial functions through activation of receptors. For instance, activation of 5-HT 1A receptors can stimulate mitochondrial transport in hippocampal neurons, suggesting the possible role of serotonin in energy distribution within the cell (Chen et al., 2007) . The stimulation of mitochondrial biogenesis mediated by 5-HT 2 receptors was demonstrated in kidney cells (Rasbach et al., 2010) . The 5-HT 2B receptor signaling was also shown to affect mitochondrial proliferation and morphology in mouse heart (Nebigil and Maroteaux, 2003) . Thus, similarly as in the above-mentioned cell types, serotonin might, through its action on mitochondrial functions, participate in the regulation of cell activities during early embryo development in the oviduct as well as during oocyte maturation in the follicle. Amireault and Dubé (2005b) showed that serotonin transfer in oocytes and preimplantation embryos can be inhibited by fluoxetine and fluvoxamine. These drugs belong in the selective serotonin reuptake inhibitor family (SSRIs), which are widely used for the treatment of psychiatric disorders associated with the serotonin system (e.g. antidepressants Prozac and Luvox). Some studies with mothers taking SSRIs during pregnancy indicate potentially hazardous effects of these antidepressants on prenatal development (Hemels et al., 2005; Wen et al., 2006; Wogelius et al., 2006) , and the results of Amireault and Dubé (2005b) suggest that SSRIs could through their action on SLC6A4 influence reproductive functions at much earlier stages than previously expected. Moreover, other serotonergic drugs could affect preimplantation embryo development as well. The 5-HT 1D /5-HT 1B agonists, such as triptans, are widely used to abort migraine and cluster headache attacks (disorders with relatively high prevalence in women), and the results of Veselá et al. (2003) showed negative effects of sumatriptan on mouse preimplantation development. Some observations in humans indicate the potential risk of triptan usage during pregnancy (Olesen et al., 2000; Källén and Lygner, 2001; Nezvalová-Henriksen et al., 2010) , but no direct data enabling estimation of the influence of these drugs in the preimplantation period are available.
Catecholamines
The treatment of mouse preimplantation embryos in vitro with b-adrenergic or a2-adrenergic agonists induced similar effects: the proportion of embryos which reached higher developmental stages was significantly reduced and the mean embryo cell number was significantly lower (Č ikoš et al., 2005, 2007) . These results indicate that activation of both types of adrenergic receptors by appropriate agonist concentration can inhibit cell proliferation in mouse preimplantation embryos. Administration of inhibitors of MAO (enzymes degrading monoamines) to female rats elevated maternal noradrenalin and serotonin levels, and led to increased occurrence of degenerated or low developmental-stage embryos, which is consistent with the idea that catecholamines and serotonin can have negative impact on preimplantation development (Mihalik et al., 2008 (Mihalik et al., , 2010 . On the other hand, Markova et al. (1990) obtained conflicting results when examining the effects of adrenalin and adrenergic antagonists on mouse preimplantation development in vitro (inhibition of proliferation or even embryo death were found in both types of ligands); the dependence of cell response on the embryo developmental stage at the time of ligand exposure, as well as on the concentration of a particular ligand, was demonstrated in this study. Altogether, these results indicate that adrenergic receptors can activate signaling pathways regulating cell proliferation and survival in preimplantation embryos. Activation of beta and alpha 2 adrenoreceptors can regulate proliferation and apoptosis in various cell types, and a variety of signaling pathways (involving MAPKs, Akt kinase, Src kinase and other signaling molecules) has been demonstrated (Alblas et al., 1993; Slotkin et al., 2000; Lindquist et al., 2000; Kim et al., 2002; Shizukuda and Buttrick, 2002; Karkoulias et al., 2006; Toll et al., 2011) .
The physiological role of adrenergic receptors in preimplantation embryos is unknown. On the other hand, there are data suggesting that these receptors could mediate some negative effects of impairment in the maternal environment. Animal experiments using the rodent model and farm animals, as well as observations in humans, have demonstrated that prenatal maternal stress can significantly affect the pregnancy outcome (Mulder et al., 2002; Lazinski et al., 2008; Gräbner et al., 2009) , and some results suggest the possible influence of maternal stress even at very early stages of embryonal development. For instance, a significant reduction in litter size was found in female hamsters stressed during early pregnancy, with fetal loss occurring between Days 5 and 10 of pregnancy (Pratt and Lisk, 1989) . In humans, it has been demonstrated that pregnancies characterized by increased maternal cortisol (a commonly used stress marker) during the first 3 weeks after conception are more likely to result in spontaneous abortion (Nepomnaschy et al., 2006) . Moreover, the therapeutic administration of drugs which can influence catecholamine levels in the maternal organism (e.g. MAO inhibitors used for treatment of some psychiatric and neurological disorders) could have a negative impact on early embryo development, as demonstrated in rats (Mihalik et al., 2008; Mihalik et al., 2010) .
Conclusions
Extensive information about signal transduction and the roles of biogenic monoamines in adult tissues is available, but specific cellular targets and functions in preimplantation embryos are practically unknown. Based on the information from other cell types, receptors for biogenic monoamines identified in preimplantation embryos (Table II) can couple preferentially to Gs and Gi proteins. Co-stimulation of Gs-and Gi-coupled receptors might be expected to antagonize each other's signaling, and the resulting physiological response could reflect the ratio of Gs-and Gi-coupled receptors expressed in the cell. However, several factors, such as possible interactions between Gs-and Gi-coupled receptors (Atkinson and Minneman, 1992; Mhaouty et al., 1995; Limon-Boulez et al., 2001) or particular subtype(s) of AC expressed in the cell (Kamenetsky et al., 2006) , can influence the resulting response. Moreover, it has been shown that under certain circumstances Gi-coupled receptors can even stimulate cAMP production in some cell types (Duzic and Lanier, 1992; Eason and Liggett, 1995; Pohjanoksa et al., 1997; Liu et al., 1999) . In addition, besides the canonical signal transduction triggered by Gs-and Gi-coupled biogenic monoamine receptors (Gs/Gi -AC -cAMP-PKA), cAMP/PK-independent signaling pathways resulting in various physiological effects have been described in various cell types (Hill et al., 1997; Raymond et al., 2001; Hur and Kim, 2002) . In the in vivo context, the preimplantation embryo is exposed to several biogenic monoamines as well as other molecules (produced by the maternal organism or by the embryo itself), thus the cell response is a result of communication between signaling pathways triggered by a variety of receptors.
Although the role of biogenic monoamines in preimplantation embryos is not fully understood, receptors for these molecules are functional and can be activated by agonists. Activation of these receptors can play an important role in physiological conditions, contributing to embryo-maternal interactions, or can influence the early embryo under unfavorable or pathological conditions. For instance, negative effects of maternal stress on early embryo development could be mediated by the action of maternal catecholamines on embryonal adrenergic receptors. Moreover, the treatment of pregnant women with anti-ulcer drugs based on histamine receptor antagonists, antimigraine drugs based on serotonin receptor agonists, or antidepressants which can regulate the metabolism or uptake of biogenic monoamines should be reconsidered in relation to the possible effects of these drugs on early embryo development and even on the fertilization. Further investigation is necessary to reveal the signaling pathways activated by biogenic monoamines in cells of preimplantation embryos, and to elucidate the role of biogenic monoamines during the preimplantation period of embryo development. 
